Shares of Encompass Health Corporation (EHC) surged 6.79% on Monday morning after the healthcare services provider reported strong third-quarter earnings that topped Wall Street expectations, leading to a wave of positive analyst reactions.
For the quarter ended September 30, Encompass Health posted adjusted earnings per share of $1.03, higher than the analyst consensus estimate of $0.94. Revenue climbed 11.9% year-over-year to $1.35 billion, also exceeding forecasts of $1.33 billion. The company reported net income of $108.2 million for the quarter.
Following the earnings beat, Barclays raised its price target on EHC to $116 from $109 while maintaining an Overweight rating on the stock. Keybanc also reiterated an Overweight rating on Encompass Health. Analysts cited the company's solid financial performance and bright growth prospects as reasons for their bullish views.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。